CEFtolozane-Tazobactam for the Empiric Anti-bacterial Treatment of Neutropenic Fever in Hematology Patients
Condition(s):Neutropenia, Febrile; Hematologic CancerLast Updated:August 14, 2023Withdrawn
Hide Studies Not Open or Pending
Condition(s):Neutropenia, Febrile; Hematologic CancerLast Updated:August 14, 2023Withdrawn
Condition(s):Bacteremia Caused by Gram-Negative BacteriaLast Updated:May 19, 2022Withdrawn
Condition(s):Pseudomonas Infections; Pseudomonas AeruginosaLast Updated:April 27, 2018Unknown status
Condition(s):Pseudomonas Aeruginosa; Pneumonia; Hematologic MalignancyLast Updated:August 24, 2023Recruiting
Condition(s):Ventilator-associated PneumoniaLast Updated:June 9, 2022Recruiting
Condition(s):Serious InfectionLast Updated:February 6, 2020Unknown status
Condition(s):Ventilator Associated Pneumonia; Antibiotic Resistant InfectionLast Updated:April 20, 2020Unknown status
Condition(s):PharmacokineticsLast Updated:September 10, 2020Completed
Condition(s):Other Infectious DiseasesLast Updated:March 15, 2022Completed
Condition(s):Gram-Negative Bacterial InfectionsLast Updated:October 2, 2019Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.